Notes - Segment Information, Etc.

Immuno-Biological Laboratories Co., Ltd. - Filing #7597262

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
647,576,000 JPY
634,223,000 JPY
13,352,000 JPY
JPY
JPY
647,576,000 JPY
14,146,000 JPY
JPY
602,749,000 JPY
JPY
602,749,000 JPY
588,602,000 JPY
Transactions with other segments
3,242,000 JPY
3,242,000 JPY
JPY
-3,242,000 JPY
JPY
JPY
JPY
JPY
16,757,000 JPY
-16,757,000 JPY
JPY
16,757,000 JPY
Other items
Depreciation
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Increase in property, plant and equipment and intangible assets
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
13,460,000 JPY
JPY
13,460,000 JPY
13,460,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.